These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 16045374)
21. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV. Townsend ML; Jackson GL; Smith R; Wilson KH Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294 [TBL] [Abstract][Full Text] [Related]
22. Depression, social support and adherence to highly active antiretroviral therapy in people living with HIV/AIDS. Gibbie T; Hay M; Hutchison CW; Mijch A Sex Health; 2007 Dec; 4(4):227-32. PubMed ID: 18082064 [TBL] [Abstract][Full Text] [Related]
23. Motivational interviewing as a behavioral intervention to increase HAART adherence in patients who are HIV-positive: a systematic review of the literature. Hill S; Kavookjian J AIDS Care; 2012; 24(5):583-92. PubMed ID: 22292452 [TBL] [Abstract][Full Text] [Related]
24. Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Antoni MH; Carrico AW; Durán RE; Spitzer S; Penedo F; Ironson G; Fletcher MA; Klimas N; Schneiderman N Psychosom Med; 2006; 68(1):143-51. PubMed ID: 16449425 [TBL] [Abstract][Full Text] [Related]
25. Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada. O'Neil CR; Palmer AK; Coulter S; O'Brien N; Shen A; Zhang W; Montaner JS; Hogg RS J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):134-41. PubMed ID: 22318879 [TBL] [Abstract][Full Text] [Related]
26. [Factors predicting detectable viral load in patients with highly active antiretroviral treatment]. Ortega L; Cuevas MJ; Pérez-Simón R; Villares C; Alcoba M; Martín V; Med Clin (Barc); 2004 Jun; 123(2):45-9. PubMed ID: 15225482 [TBL] [Abstract][Full Text] [Related]
27. Gender moderates the influence of psychosocial factors and drug use on HAART adherence in the context of HIV and childhood sexual abuse. Wilson SM; Sikkema KJ; Ranby KW AIDS Care; 2014; 26(8):959-67. PubMed ID: 24410324 [TBL] [Abstract][Full Text] [Related]
28. Self-reevaluation as a critical component in sustained viral load change for HIV+ adults with alcohol problems. Longmire-Avital B; Golub SA; Parsons JT Ann Behav Med; 2010 Oct; 40(2):176-83. PubMed ID: 20668976 [TBL] [Abstract][Full Text] [Related]
29. Evaluating the relationship between adherence to Highly Active Antiretroviral Therapy (HAART) and social and clinical characteristics in Chinese patients with HIV. Wang YY; Wang T; Yan H; D'Amato RC; Wang W; Li SY AIDS Care; 2019 Jan; 31(1):14-18. PubMed ID: 30430839 [TBL] [Abstract][Full Text] [Related]
30. Outpatient pharmacy care and HIV viral load response among patients on HAART. Castillo E; Palepu A; Beardsell A; Akagi L; Yip B; Montaner JS; Hogg RS AIDS Care; 2004 May; 16(4):446-57. PubMed ID: 15203413 [TBL] [Abstract][Full Text] [Related]
31. The impact of stigma on medication adherence among HIV-positive adolescent and young adult females and the moderating effects of coping and satisfaction with health care. Martinez J; Harper G; Carleton RA; Hosek S; Bojan K; Clum G; Ellen J; AIDS Patient Care STDS; 2012 Feb; 26(2):108-15. PubMed ID: 22149767 [TBL] [Abstract][Full Text] [Related]
32. Predictors and Evolution of Antiretroviral Therapy Adherence Among Perinatally HIV-Infected Adolescents in Brazil. Côté J; Delmas P; de Menezes Succi RC; Galano E; Auger P; Sylvain H; Colson S; Machado DM J Adolesc Health; 2016 Sep; 59(3):305-310. PubMed ID: 27320032 [TBL] [Abstract][Full Text] [Related]
33. Home-based study of anti-HIV drug regimen adherence among HIV-infected women: feasibility and preliminary results. Durante AJ; Bova CA; Fennie KP; Danvers KA; Holness DR; Burgess JD; Williams AB AIDS Care; 2003 Feb; 15(1):103-15. PubMed ID: 12655838 [TBL] [Abstract][Full Text] [Related]
34. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. Cook JA; Cohen MH; Burke J; Grey D; Anastos K; Kirstein L; Palacio H; Richardson J; Wilson T; Young M J Acquir Immune Defic Syndr; 2002 Aug; 30(4):401-9. PubMed ID: 12138346 [TBL] [Abstract][Full Text] [Related]
35. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903 [TBL] [Abstract][Full Text] [Related]
36. Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients. Fong OW; Ho CF; Fung LY; Lee FK; Tse WH; Yuen CY; Sin KP; Wong KH HIV Med; 2003 Apr; 4(2):133-8. PubMed ID: 12702134 [TBL] [Abstract][Full Text] [Related]
37. Housing status and the health of people living with HIV/AIDS. Milloy MJ; Marshall BD; Montaner J; Wood E Curr HIV/AIDS Rep; 2012 Dec; 9(4):364-74. PubMed ID: 22968432 [TBL] [Abstract][Full Text] [Related]
38. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
39. Microsocial environmental influences on highly active antiretroviral therapy outcomes among active injection drug users: the role of informal caregiving and household factors. Knowlton AR; Arnsten JH; Gourevitch MN; Eldred L; Wilkinson JD; Rose CD; Buchanan A; Purcell DW; J Acquir Immune Defic Syndr; 2007 Nov; 46 Suppl 2():S110-9. PubMed ID: 18089980 [TBL] [Abstract][Full Text] [Related]
40. Men's serostatus disclosure to parents: associations among social support, ethnicity, and disease status in men living with HIV. Fekete EM; Antoni MH; Lopez CR; Durán RE; Penedo FJ; Bandiera FC; Fletcher MA; Klimas N; Kumar M; Schneiderman N Brain Behav Immun; 2009 Jul; 23(5):693-9. PubMed ID: 19486655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]